Charcot-Marie-Tooth disease: An update

Current Opinion in Neurology

Volumn 17, Issue 5, 2004, Pages 579-585

  Shy, Michael E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axonal transport; Charcot Marie Tooth; Neurons; Protein trafficking; Schwann cells

Indexed keywords

ANTIGESTAGEN; ASCORBIC ACID; DYNACTIN; GLYCINE TRANSFER RNA LIGASE; HELICASE; MITOCHONDRIAL PROTEIN; MUTANT PROTEIN; ONAPRISTONE; RAB7 PROTEIN; RNA HELICASE;

AMYOTROPHIC LATERAL SCLEROSIS; AUTOSOMAL RECESSIVE DISORDER; CELL INTERACTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; DEMYELINATION; DISEASE ACTIVITY; DISEASE CLASSIFICATION; EXPERIMENTAL MODEL; EXPERIMENTAL MOUSE; EXPERIMENTAL RAT; GENE CLUSTER; GENE FUNCTION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC DISORDER; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOTOR NEURON DISEASE; MUTATION RATE; NERVE FIBER DEGENERATION; NERVE FIBER TRANSPORT; NEUROPATHY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; PHENOTYPE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REVIEW; RODENT; SCHWANN CELL; SPINAL MUSCULAR ATROPHY; WHITE MATTER;

ANIMALS; ASCORBIC ACID; AXONAL TRANSPORT; CHARCOT-MARIE-TOOTH DISEASE; GLYCINE-TRNA LIGASE; HEAT-SHOCK PROTEINS; HUMANS; MEMBRANE PROTEINS; MITOCHONDRIAL PROTEINS; MYELIN PROTEINS; NERVE FIBERS, MYELINATED; NUCLEAR PROTEINS; PROGESTERONE; PROTEIN TRANSPORT; PROTEIN-TYROSINE-PHOSPHATASE; RAB GTP-BINDING PROTEINS; SCHWANN CELLS; TRANSCRIPTION FACTORS;

EID: 6944246275     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200410000-00008     Document Type: Review

References (30)

1. Krajewski KM, Shy ME. Genetic testing in neuromuscular disease. Neurol Clin North Am 2004; 143: in press.
2. Suter U, Scherer SS. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 2003; 4:714-726.
3. Michailov GV, Sereda MW, Brinkmann BG, et al. Axonal neuregulin-1 regulates myelin sheath thickness. Science 2004; 304:700-703.
4. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet 2003; 33:455-456.
5. Zuchner S, Mersiyanova IV, Muglia M, et al. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 2004; 36:449-451. Epub 4 April 2004.
6. Chen H, Detmer SA, Ewald AJ, et al. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003; 160:189-200. Epub 13 January 2003.
7. Zhao C, Takita J, Tanaka Y, et al. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1Bbeta. Cell 2001; 105:587-597.
8. Street VA, Bennett CL, Goldy JD, et al. Mutation of a putative protein degradation gene LITAF/SIMPLE in Charcot-Marie-Tooth disease 1C. Neurology 2003; 60:22-26.
9. Verhoeven K, De Jonghe P, Coen K, et al. Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. Am J Hum Genet 2003; 72:722-727.
10. Jordens I, Fernandez-Borja M, Marsman M, et al. The Rab7 effector protein RILP controls lysosomal transport by inducing the recruitment of dynein-dynactin motors. Curr Biol 2001; 11:1680-1685.
11. Senderek J, Bergmann C, Weber S, et al. Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/11p15. Hum Mol Genet 2003; 12:349-356.
12. Irobi J, Impe KV, Seeman P, et al. Hot-spot residue in small heat-shock protein 22 causes distal motor neuropathy. Nat Genet 2004; 36:597-601. Epub 2 May 2004.
13. Benndorf R, Welsh MJ. Shocking degeneration. Nat Genet 2004; 36:547-548.
14. Evgrafov OV, Mersiyanova I, Irobi J, et al. Mutant small heat-shock protein 27 causes axonal Charcot-Marie-Tooth disease and distal hereditary motor neuropathy. Nat Genet 2004; 36:602-606. Epub 2 May 2004.
15. Sun X, Fontaine JM, Rest JS, et al. Interaction of human HSP22 (HSPB8) with other small heat shock proteins. J Biol Chem 2004; 279:2394-2402. Epub 31 October 2003.
16. Benndorf R, Sun X, Gilmont RR, et al. HSP22, a new member of the small heat shock protein superfamily, interacts with mimic of phosphorylated HSP27 ((3D)HSP27). J Biol Chem 2001; 276:26753-26761. Epub 7 May 2001.
17. Jordanova A, De Jonghe P, Boerkoel CF, et al. Mutations in the neurofilament light chain gene (NEFL) cause early onset severe Charcot-Marie-Tooth disease. Brain 2003; 126:590-597.
18. Antonellis A, Ellsworth RE, Sambuughin N, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003; 72:1293-1299.
19. Senderek J, Bergmann C, Stendel C, et al. Mutations in a gene encoding a novel SH3/TPR domain protein cause autosomal recessive Charcot-Marie-Tooth type 4C neuropathy. Am J Hum Genet 2003; 73:1106-1119. Epub 21 October 2003.
20. Chen YZ, Bennett CL, Huynh HM, et al. DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004; 74:1128-1135. Epub 21 April 2004.
21. Hanemann CO, Bergmann C, Senderek J, et al. Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation. Arch Neurol 2003; 60:605-609.
22. Taylor RA, Simon EM, Marks HG, Scherer SS. The CNS phenotype of X-linked Charcot-Marie-Tooth disease: more than a peripheral problem. Neurology 2003; 61:1475-1478.
23. Li J, Krajewski KM, Lewis RA, Shy ME. Loss-of-function phenotype of hereditary neuropathy with liability to pressure palsies. Muscle Nerve 2004; 25:205-210.
24. Shy ME, Jani A, Krajewski KM, et al. Phenotypic clustering in MPZ mutations. Brain 2004; 127:371-384.
25. Boerkoel CF, Takashima H, Garcia CA, et al. Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation. Ann Neurol 2002; 51:190-201.
26. Wise CA, Garcia CA, Davis SN, et al. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMTIA duplication. Am J Hum Genet 1993; 53:853-863.
27. Sereda M, Griffiths I, Puhlhofer A, et al. A transgenic rat model of Charcot-Marie-Tooth disease. Neuron 1996; 16:1049-1060.
28. Magyar JP, Martini R, Ruelicke T, et al. Impaired differentiation of Schwann cells in transgenic mice with increased PMP22 gene dosage. J Neurosci 1996; 16:5351-5360.
29. Sereda MW, Meyer Zu Horste G, Suter U, et al. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 2003; 9:1533-1537.
30. Passage E, Norreel JC, Noack-Fraissignes P, et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 2004; 10:396-401. Epub 21 March 2004.